Information:
Error:
ID
17551
Description
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis; ODM derived from: https://clinicaltrials.gov/show/NCT00076336
Link
https://clinicaltrials.gov/show/NCT00076336
Keywords
Versions (1)
- 9/23/16 9/23/16 -
Uploaded on
September 23, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis NCT00076336
Eligibility Hepatitis NCT00076336
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis NCT00076336
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Hepatitis B, Chronic; Decompensated | Decompensated Chronic Hepatitis B Related Liver Cirrhosis
Item
documented decompensated chronic hepatitis b defined by all of the following: 1. clinical history compatible with decompensated chronic hepatitis b related cirrhosis;
boolean
C0524909 (UMLS CUI [1,1])
C0205434 (UMLS CUI [1,2])
C0524909 (UMLS CUI [2,1])
C0205434 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0023890 (UMLS CUI [2,4])
C0205434 (UMLS CUI [1,2])
C0524909 (UMLS CUI [2,1])
C0205434 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0023890 (UMLS CUI [2,4])
Child-Pugh-Turcotte score
Item
2. child-turcotte-pugh score > 7 points.
boolean
C3854424 (UMLS CUI [1])
Liver Cirrhosis Evidence of | Portal Hypertension Evidence of
Item
evidence of hepatic cirrhosis or portal hypertension.
boolean
C0023890 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0020541 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
C0332120 (UMLS CUI [1,2])
C0020541 (UMLS CUI [2,1])
C0332120 (UMLS CUI [2,2])
Inclusion criteria Study Protocol
Item
other protocol-defined inclusion criteria may apply.
boolean
C1512693 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
patient is pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
HCV coinfection | HDV Coinfection | HIV coinfection
Item
patient is coinfected with hepatitis c virus (hcv), hepatitis d virus (hdv), or human immunodeficiency virus (hiv).
boolean
C1698259 (UMLS CUI [1])
C0011220 (UMLS CUI [2,1])
C0275524 (UMLS CUI [2,2])
C4062778 (UMLS CUI [3])
C0011220 (UMLS CUI [2,1])
C0275524 (UMLS CUI [2,2])
C4062778 (UMLS CUI [3])
Lamivudine | adefovir | Nucleosides Investigational Against Hepatitis B Virus | nucleotide analog
Item
patient previously received lamivudine, adefovir, or an investigational anti-hepatitis b virus (hbv) nucleoside or nucleotide analog at any time
boolean
C0209738 (UMLS CUI [1])
C0050175 (UMLS CUI [2])
C0028621 (UMLS CUI [3,1])
C1517586 (UMLS CUI [3,2])
C0521124 (UMLS CUI [3,3])
C0019169 (UMLS CUI [3,4])
C0597107 (UMLS CUI [4])
C0050175 (UMLS CUI [2])
C0028621 (UMLS CUI [3,1])
C1517586 (UMLS CUI [3,2])
C0521124 (UMLS CUI [3,3])
C0019169 (UMLS CUI [3,4])
C0597107 (UMLS CUI [4])
interferon | Biological Response Modifier Therapy Hepatitis B
Item
patient has received interferon or other immunomodulatory treatment for hbv infection in the 12 months before screening for this study.
boolean
C0733470 (UMLS CUI [1])
C0005527 (UMLS CUI [2,1])
C0019163 (UMLS CUI [2,2])
C0005527 (UMLS CUI [2,1])
C0019163 (UMLS CUI [2,2])
Exclusion Criteria Study Protocol
Item
other protocol-defined exclusion criteria may apply.
boolean
C0680251 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])